研究单位：[1]Drug Induced Liver Disease Study Group[2]Department of gastroenterology of Yunnan first people's hospital Kunming,China[3]Department of gastroenterology,the first affiliated hospital of Kunming medical university Kunming,China[4]Department of gastroentrology,the first hospital of Kunming Kunming,China[5]Department of infectious disease,Kunming general hospital of Chengdu military Kunming,China[6]Department of infectious disease,the first affiliated hospital of Kunming medical university Kunming,China[7]Department of rheumatology of Yunnan first people's hospital Kunming,China[8]Hepatology center,the second affiliated hospital of Kunming medical university Kunming,China[9]Department of hepatology,Gansu provincial hospital of TCM Lanzhou,China[10]Department of infectious disease of Lanzhou military general hospital Lanzhou,China
研究目的：
This is a multi-center, open-enrollment, retrospective, non-interventional epidemiologic study without any clinical treatment. Its primary objective is to understand 1) incidence of drug-induced liver injury, including incidences among all the hospitalized patient, among patients in department of hepatic diseases, digestive diseases, oncology, hematology etc., individually; 2) epidemiologic characteristics of drug-induced liver injury, including suspected medications, clinical types, histological characteristics, severity and outcomes.
